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ABSTRACT  
 
Purpose: Chronic pain is a highly prevalent and debilitating condition, and there is a pressing 
need to find safe, effective and affordable treatments to tackle this public health issue. This 
pilot study aimed to assess whether therapeutic exercises supplemented by transcutaneous 
electrical nerve stimulation induces a greater hypoalgesic effect than therapeutic exercises 
supplemented by sham transcutaneous electrical nerve stimulation, in an elderly population 
suffering from chronic pain.  
Materials and methods: Eighteen elderly participants suffering from chronic pain 
completed a therapeutic exercise program consisting of 45-min group sessions administered 
twice a week for four weeks. Half of the participants received real transcutaneous electrical 
nerve stimulation during the exercise sessions, while the others received sham transcutaneous 
electrical nerve stimulation. Participants completed pain questionnaires (McGill Pain 
Questionnaire, Brief Pain Inventory, Beck Depression Index) before and after the 
intervention, and recorded their pain levels on an 11-point numerical rating scale before and 
after each session (Clinical Trial.Gov ID : NCT02445677).  
Results and conclusion: Our results suggest that supplementing exercise sessions with 
transcutaneous electrical nerve stimulation does not improve the long-term outcomes of 
elderly patients suffering from chronic pain, but does induce short-term hypoalgesia during 
exercise sessions. Our study also offers valuable guidelines for the implementation of a future 
and adequately powered study looking at this research question. 
 
Keywords: Transcutaneous electrical nerve stimulation; Exercise; Chronic Pain; Pain; Aged.  
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Introduction 
The proportion of people aged 65 and older is rising in Canada, from 8% in 1960 to 16% in 
2015. It is predicted to continue increasing, reaching up to 25% of the Canadian population 
by 2035 [1]. Such aging of the population is of great significance from a public health 
standpoint, as many health conditions - including chronic pain - become significantly more 
prevalent with age [2,3]. Chronic pain is made particularly difficult to treat in elderly patients 
by the elevated rates of comorbidities, and by the presence of polymedication and its often-
incapacitating side-effects [4,5]. It is essential that effective, low-cost treatment protocols be 
developed for the elderly population suffering from chronic pain.  
Therapeutic exercises and transcutaneous electrical nerve stimulation (TENS), two 
modalities frequently used by physical therapists, that have been proposed as treatment 
options for chronic pain [6-11]. TENS, perhaps the lesser known of these two interventions, 
consists in applying electrical stimulation through skin electrodes to depolarize peripheral 
nerve fibers and induce hypoalgesia [12]. Multiple studies have demonstrated the hypoalgesic 
effects of TENS in patients suffering from various conditions, such as migraines, knee 
osteoarthritis, multiple sclerosis, and pelvic pain [13-16]. There is evidence to show that age 
can influence patients’ response to TENS. For instance, a recent study evaluating the effects 
of TENS in different age groups (young adults, middle-aged adults, older adults) has shown 
that while all participants experienced hypoalgesia and decreased pain sensitivity following 
TENS, a greater stimulation intensity was required to induce hypoalgesia in elderly 
participants [17]. Unfortunately, because this study did not include a control condition, we 
cannot determine whether the observed hypoalgesia resulted from the TENS or from a placebo 
effect. Moreover, while elderly participants seem more responsive to the placebo effect [18], 
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at least one study suggests they may also be less susceptible to TENS-induced hypoalgesia 
than younger subjects [19]. 
Treatment approaches that include both TENS and therapeutic exercises have been 
studied [20-24], but only on adult participants, and never with the two modalities 
superimposed on each other. The study by Hawamdeh et al. (2014) [23], which comes closest 
to a concomitant application (TENS and exercises were applied sequentially: 15 minutes of 
TENS immediately followed by 15 minutes of exercise), indeed seems to show better 
outcomes in the real TENS group compared to the sham TENS group, although the scarcity 
of quantifiable data reported makes this study difficult to interpret. Considering these results, 
as well as the varying response to TENS observed across different age groups and the special 
challenges faced by an aged population mentioned previously, there is a need to evaluate the 
pain-relief effects of joint therapeutic exercises + TENS program specifically in elderly 
patients. 
Accordingly, we designed a protocol to study whether therapeutic exercises 
supplemented by TENS induce a greater hypoalgesic effect than therapeutic exercises 
supplemented by sham TENS, in an elderly population suffering from chronic pain. The 
objectives of the present pilot study were to estimate the effectiveness and effect size of our 
intervention, and to assess the feasibility of our protocol for the implementation of a future, 
adequately powered randomized controlled trial looking at the combined effect of TENS and 
therapeutic exercises in elderly individuals suffering from chronic pain. 
Material and methods 
Study Design 
We conducted a single-blind randomized controlled trial to test our hypothesis. Data was 
collected over two intervention periods, the first one in February 2017 and the second in July 
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2017. The intervention protocols were carried out over 4 weeks, and consisted of eight 45-
minute-long group therapeutic exercise sessions administered twice a week. Participants were 
randomly assigned to the experimental and control groups using a random number table 
designed by the statistician of the Research Center on Aging, using Minitab Statistical 
Software (version 15.0; State College, PA). The principal investigator assigned the 
participants to the two groups. The participants and the person assessing the outcomes were 
blinded to the interventions during the entire study. The experimental group received real 
TENS stimulation during therapeutic exercise sessions, whereas the control group received 
sham TENS stimulation during those same sessions. Our protocol satisfied the ethical 
standards of the local institutional research committee (Centre intégré universitaire de santé 
et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke - #2017-671-
Institut universitaire de gériatrie de Sherbrooke), in accordance with the Declaration of 
Helsinki of 1964 and its later amendments. All participants signed an informed consent form, 
approved by the research committee, before taking part in the study. This clinical trial was 
registered in Clinical Trial.Gov (ID : NCT02445677) before enrolment of the first participant. 
Participants  
To be included in our study, participants were required to be aged 65 or older, speak French, 
and suffer from chronic (> 6 months) pain. We excluded participants with unstable analgesic 
medication, a diagnosis of cancer, cognitive deficits, prior experience with TENS, or for 
whom TENS was contraindicated [see 12]. In order to optimize the efficacy of the TENS, we 
asked participants to refrain from consuming caffeine during the 6 hours preceding each 
treatment session [22]. The study (recruitment and intervention) was conducted in two 
retirement residences in the Sherbrooke area: Chartwell Villa de l’Estrie (February 2017) and 
Chartwell Seigneuries du Carrefour (July 2017).  
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Therapeutic Exercise Program  
The therapeutic exercise program consisted of group training sessions taking place twice a 
week over a period of four weeks, under the supervision of fourth-year physiotherapy students 
(with ample knowledge to adequately oversee the exercises and handle TENS). Sessions 
lasted 45 minutes and were comprised of a general cardiovascular warm-up (15 mins) 
followed by strengthening exercises targeting major muscle groups in the four limbs and using 
elastic bands for resistance (20 mins), and ending with stretching and relaxation (10 mins) 
(see Supplementary Table S1 for a more detailed breakdown of the sessions).  Sessions all 
took place in the early afternoon and were spread throughout the week to allow for appropriate 
(> 36h) recovery. 
TENS  
This study used the Biomed 2000XL 2-channel TENS unit manufactured by Vitality Medical, 
with carbon rubber electrodes. The electrodes were applied on each participant’s most painful 
region, as identified at the beginning of the first session. The TENS parameters were set as 
per conventional mode recommendations (100 Hz, 60µs), and the intensity was individually 
adjusted such that the stimulation was intense but not painful [12]. For participants in the 
experimental group, TENS intensity remained constant throughout the entire therapeutic 
exercise session. For participants in the control group, TENS intensity was maintained for 15 
seconds before being gradually reduced; the TENS machines were then turned off for the 
entire duration of the exercise session, unbeknownst to the participants. To ensure that 
participants remained blinded to the experimental conditions, they were systematically told 
that TENS is perceived differently by every individual and that it is normal for some people 
to feel it more or less than others. 
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Outcome Measures 
All outcome measures were selected as per recommendations from the Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials [25,26]. We used the Short-Form 
McGill Pain Questionnaire to assess the sensory and affective quality of pain in our subjects. 
This tool allows participants to rate the extent to which given descriptors (ex. “stabbing”, 
“dull”, “suffocating”, etc.) apply to their pain, such that a higher score corresponds to greater 
pain, out of a maximum score of 45 [27]. This tool shows adequate content validity, sensitivity 
to change (> 0.8), and test-retest reliability (0.75-0.93), and is widely used in pain research 
[25-28].  
We used the Brief Pain Inventory to assess the severity of pain and the interference of 
pain with physical functioning. This tool provides two outcome measures (severity of pain 
[questions 3-6], out of 40; and interference of pain with physical functioning [question 9 a-g], 
out of 70), and has been shown to have satisfactory test-retest reliability (0.83-0.98) and 
validity (Cronbach’s alpha = 0.77-0.91) [25,26,29].  
We used the Beck Depression Inventory to assess the impact of pain on emotional 
functioning. This tool consists of 21 questions, each with at least four possible answers 
ranging in intensity (0-3, for a maximum score of 63). The validity of this questionnaire 
depends on depressive symptoms having been present for at least 3 weeks [39]. This tool 
shows adequate test-retest reliability (0.6-0.9) and good sensitivity (89%) and specificity 
(90%) when scores are greater than 21 [25,26,31]. 
We used a 0-10 numerical rating scale to assess pain intensity (0: no pain; 10: worst 
pain imaginable) before and after each training session. We selected this scale because it is 
easier to understand than the visual analog scale for an elderly population [25]. It has relatively 
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high reliability [32], and has been demonstrated to be adequate when studying an elderly 
population suffering from persistent pain [25,26,33,34].  
Pain intensity was assessed before and after each of the 8 training sessions, for a total 
of 16 data points per participants. The three questionnaires were administered twice: once 
during the week preceding the first training session (T0), and a second time a week after the 
final (8th) training session (T1).  
Statistical analysis  
Between-group comparisons were made using Student’s t-tests. Demographic characteristics 
were compared to make sure that the two groups were similar. Questionnaire scores (obtained 
at T0 and T1) were compared to rule out an initial difference between the two groups and to 
test for between-group difference after the intervention. The magnitude of improvement (i.e. 
∆, the change in questionnaire scores between T0 and T1 calculated as T0-T1) was also 
compared between the two groups for all questionnaires, to determine whether the 
experimental group had improved to a greater extent than the control group. Finally, within-
group analysis (paired-sample t-tests) were used to assess whether our intervention had 
induced a statistically significant change in either group. Because of the small sample size 
(n=18) and the results from the Kolmogorov-Smirnov tests suggesting the presence of non-
normally distributed data for a small number of variables, non-parametric tests were 
additionally used for between- (Mann-Whitney U test) and within-group (Wilcoxon signed-
rank test) comparisons. Results confirmed no difference between parametric and 
nonparametric approaches; therefore, only parametric statistics are reported. 
 Independent and paired-sample t-tests as well as non-parametric equivalents were 
performed using SPSS (version 19.0 for Windows, Chicago, IL, USA). In an effort to increase 
reproducibility and reduce the rate of false positives in the literature, and to promote scientific 
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rigor within the field, we embrace the changes proposed by Benjamin et al. [35], wherein the 
threshold for statistical significance is lowered to p < 0.005 and p-values ranging between 
0.05 and 0.005 are instead considered “suggestive”. 
The absolute and relative changes in pain intensity were calculated for each participant 
over each session. Given the large proportion of missing pain scores (see the Results and 
Discussion sections), we did not attempt to establish statistical significance for this outcome 
measure, instead keeping only to a descriptive analysis; as per recommendations from the 
Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials, we report 
absolute changes in pain intensity (minimal clinical change: ∆ ≥ 2), as well as the percentage 
of patients obtaining reduction in pain intensity of at least 30% and 50% from baseline [25].  
Results 
Participants  
In total, 21 participants (aged 83 ± 4 years old) met our criteria, but three of them dropped out 
before the beginning of the first session (due to lack of interest or scheduling conflicts), such 
that 18 participants gave their informed consent and took part in the experiment. Our sample 
consisted of only women, as no men volunteered to participate in our study. Eleven 
participants were recruited from Villa de l’Estrie, and seven from Les Seigneuries du 
Carrefour. Six participants were suffering from axial pain, five from lower limb pain, and 
seven from upper limb pain. Participants had been suffering from chronic pain for an average 
of 22 years.   
Our protocol planned for eight training sessions delivered twice a week for 4 weeks. 
Unfortunately, a flu epidemic at Villa de l’Estrie made it impossible to deliver the last training 
session; those participants thus attended only up to 7 sessions each. All sessions successfully 
took place at Seigneuries du Carrefour. Attendance to the training sessions was similar across 
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the experimental and control groups (average participation: 5 ± 2 sessions). Three participants 
from Villa de l’Estrie (one from the experimental group, two from the control group) 
discontinued their participation in the study during the intervention period (one participant 
caught the zona virus; another lost interest in the study; the last had too many other medical 
appointments to attend). In order to complete data analysis, we accounted for the three drop 
outs as follows: for the questionnaires, we set missing T1 scores equal to their respective T0 
scores; for the pain scores (recorded at the beginning and end of each session), we retained 
scores for the attended sessions, such that the drop out participants were no different from 
other participants with imperfect attendance. 
Outcome measures  
Questionnaires  
We found that it was necessary for a team member to assist our participants while they were 
filling in the questionnaires, as participants were often unsure how to answer questions. 
Results from the three questionnaires can be found in Table 1.  
 
[Insert Table 1 here] 
 
Independent t-tests showed no statistically significant difference in post-treatment (T1) scores 
between groups and paired-sample t-tests for dependent samples showed no statistically 
significant improvement on any questionnaires (all p-values > .05; see Table 1). The only 
statistically suggestive effect was observed on McGill Pain Questionnaire scores: the 
experimental group showed a small decrease in scores, while the control group showed a 
smaller still increase in scores, such that the evolution appears different between the two 
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groups (p = 0.04); however, this evolution was not  clinically significant in either group 
(minimal clinical difference ≥ 5).  
 
Numerical pain rating scale 
We measured pain intensity using the numerical rating scale at the beginning and end of each 
training session to determine whether TENS potentiated the short-term hypoalgesic effects of 
exercise. In total, we aimed to collect 144 (18 participants * 8 sessions = 144) pairs of pre-
post pain scores; however, because of poor attendance and drop outs, we were only able to 
collect 98 data pairs (52 in the experimental group, and 46 in the control group - 32% missing 
data overall). Moreover, despite our inclusion criteria requiring that all our participants suffer 
from chronic pain, we had an unfortunately large number of initial pain scores of 0 throughout 
the intervention (15 in the experimental group, and 5 in the control group, for a total of 20 out 
of 98 data pairs). An absence of pain in our patients is desirable in the grand scheme of things, 
but it obviously generates a substantial floor effect for our intervention. We therefore elected 
to exclude those 20 data pairs with an initial score of 0. While this might have jeopardized our 
ability to draw statistically significant conclusions, our 32% missing data had already done 
away with that option, and inclusion of these data would have artificially decreased the effect 
of our intervention and biased our group comparisons by virtue of their asymmetrical 
distribution. For the sake of transparency, we have included in the supplementary materials a 
replication of our analysis which does not exclude those 20 data pairs - as expected, results 
obtained this way follow the exact same trend as the results presented in the main text, albeit 
with smaller effects.  
 
[Insert Table 2 here] 
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The average hypoalgesia induced in the two groups during each session is shown in Table 2, 
and was calculated as an average of the absolute (and relative) hypoalgesia induced in each 
participant, as per their pre- and post-session pain scores. The number of data points making 
up each average (i.e. the number of participants present for the session and with a pre-session 
score greater than 0) is reported. Notably, while no session induced significant (≥ 2) pain relief 
in the control group, 5 out of 8 training sessions induced clinically significant pain relief in 
the experimental group. With a significance threshold of ≥ 30%, this figure increases to 6 
sessions.  
 
[Insert Table 3 here] 
 
The average hypoalgesia induced in each participant similarly also favors the experimental 
group over the control group (Table 3). These scores were obtained by averaging the absolute 
(and relative) hypoalgesia induced in each participant as per their pre- and post-session pain 
scores. The number of data points making up each average (i.e. the number of sessions 
attended and with a pre-session score greater than 0) is reported. Six experimental participants 
experienced clinically significant hypoalgesia (≥ 2 and ≥ 30%) on average when they attended 
the sessions, compared to only two control participants.   
 
[Insert Table 4 here] 
 
The average hypoalgesia induced across all sessions and all participants (calculated as the 
average of all data points) was clinically significant in the experimental group, but not in the 
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control group (Table 4). The proportion of sessions during which significant hypoalgesia was 
induced (calculated as the number of instances for which the delta in pain scores met the 
threshold, divided by the total number of delta pain scores recorded) is also reported for both 
groups with respect to the various thresholds.  
Discussion 
This pilot study assessed the effect of an exercise program combined with conventional TENS, 
compared to an exercise program combined with sham TENS, on chronic pain in an elderly 
population. 
 
Effectiveness of the intervention  
Results obtained from the three questionnaires at baseline and post-intervention show no 
difference between the two groups, except for a statistically suggestive difference in McGill 
Pain Questionnaire score changes (∆) between the experimental and control groups post-
intervention, resulting from a non-clinically significant improvement (the McGill Pain 
Questionnaire threshold for clinical significance is ∆ ≥ 5, out of a maximum score of 45; see 
Strand et al. [28]). Our results therefore suggest that combining TENS with a training program 
does not improve the overall treatment outcome in terms of quality of pain, physical 
functioning, and emotional functioning in elderly patients suffering from chronic pain. 
Pain intensity 
While the results reported in Table 2 seem to indicate that the hypoalgesia induced 
during each session was greater in the experimental group than in the control group, it is 
important to keep in mind that the number of data points making up each average varies 
between groups and between sessions (as a function of attendance and the data excluded 
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because of an initial pain score of 0). Because of this, session averages may be overly 
influenced by outliers, should these outliers occur in low-attendance sessions. For instance, 
the average hypoalgesia observed in the experimental group during session 8 seems 
remarkable - but this value only comprises data from two participants, one of which reported 
an hypoalgesia of 8. As such, this figure can be rather misleading if it is not interpreted 
attentively. Nonetheless, while the size of the effect is difficult to estimate accurately at a 
glance, a clear trend favoring the experimental group transpires from the data.  
The average hypoalgesia induced in each participant throughout the training sessions 
(Table 3) perhaps constitutes a more valid and more easily interpretable outcome measure, 
because it is not biased by attendance; each result reflects the average hypoalgesia experienced 
by a given participant, regardless of the participant’s attendance - and, more importantly, 
regardless of the overall group attendance. Similarly, while the average hypoalgesia induced 
in both groups and the proportion of hypoalgesia-inducing sessions in both groups (Table 4) 
were obtained from a relatively small data set and might accordingly be biased by random 
noise, these results are not at risk of being systematically biased by the attendance rate.  
Considering the limitations and possible biases listed above, we recognize that any one 
of our results, taken individually, does not offer robust evidence supporting the addition of 
TENS to an exercise program. We should also reiterate that statistical significance was not 
established, and that our analysis is purely descriptive. However, the fact that our results 
consistently and unequivocally converge in favor of the experimental group, regardless of 
how the data is analyzed, lends a certain degree of credibility to our conclusion that exercise 
sessions supplemented with TENS probably result in short-term hypoalgesia, unlike exercise 
sessions alone.  
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Limitations and recommendations for future trials 
Sample 
The first and most obvious limitation in our study is the low attendance rate we experienced. 
A follow-up study should consider adopting strategies to increase attendance (e.g. phone 
reminders), while also accounting for the expected low attendance when determining the study 
sample size. The site of musculoskeletal injury/pain may also correlate with the success of the 
intervention [36] - a variable that has not yet been studied, to the best of our knowledge. A 
larger sample would be needed in order to investigate this possible effect.  
Given that our sample consists only of women, we cannot generalize our results to 
male patients. A larger-scale study would do well to attempt to recruit a significant proportion 
of male participants, to increase the external validity of the study. Sex (and/or gender) is an 
important factor to consider, seeing as some studies have shown that women perceive pain 
differently than men. For instance, women seem to have a lower pain threshold than men [37], 
and have been said to preferentially recruit “emotional brain circuits” when subjected to pain 
[38]. Unfortunately, men suffering from chronic pain have a lower tendency than women to 
seek treatment [39], which makes the gender distribution of our sample unsurprising, if 
undesirable.  
Some of our results might also have been biased by our participants exhibiting 
relatively mild symptoms. For instance, the low McGill Pain Questionnaire scores obtained 
at baseline could have potentially led to a floor effect, artificially limiting the effect size of 
our intervention. Similarly, the absence of pain reported relatively frequently by our 
participants at the beginning of training sessions considerably limited our ability to generate 
hypoalgesia in those patients. In order to avoid these problems, a follow-up study should 
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consider narrowing the inclusion criteria, for example by requiring that participants suffer 
from constant pain.  
Instruments  
The tools we had selected to assess outcome (pain scale and questionnaires) proved 
surprisingly difficult to understand for our patients. This was unexpected, as they are all well-
validated and extremely common in pain research. Eventually, all participants understood how 
to answer the various questionnaires, but sometimes only after several rounds of explanations. 
Therefore, while these tools are designed to be self-administered, our experience (see also 
Harvey et al. [40]) shows that the presence of a research team member is necessary during 
completion of the questionnaires, to ensure that the results obtained are valid, at least for 
elderly study participants.  
Another limitation in our study relates to TENS parameters. In order to yield optimal 
results, conventional TENS intensity should be adjusted throughout a training session, such 
that the stimulation is always perceived as being intense but non-painful (as the nervous 
system habituates to the stimulation, patients feel the TENS as being less and less intense, 
which must be corrected for by gradually increasing the intensity, often multiple times within 
a session; see Bélanger [12]; Moran et al. [41]; and Pantaleao et al. [42]. However, in order to 
keep our participants blinded to their group allocation, we chose not to increase TENS 
intensity throughout the training session. This might have resulted in suboptimal TENS 
parameters, which could have translated in decreased treatment effects [42]. On the other 
hand, a recent study conducted on patients suffering from clinical pain (as opposed to the 
experimental pain induced by Pantaleao et al. [42]) has shown that adjusting the TENS 
intensity throughout a session had no effect on the hypoalgesia induced [43]. In any case, it 
would be possible for a future study to avoid this limitation altogether by telling participants 
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they would either receive ‘conventional’ (experimental group) or ‘microcurrent’ (control 
group) TENS. Therapists could then adjust stimulation intensity in both groups throughout 
training sessions, informing experimental participants that the sensation should be intense but 
not painful, while informing control participants that the stimulation should remain 
‘undetectable’.  
Finally, seeing as no long-term follow-up assessment took place, we cannot determine 
whether our intervention had any longer lasting effects. As such, it would be worthwhile in a 
future study to include follow-up measures, for example 4 weeks and 8 weeks after the end of 
the training program 
Conclusion 
This pilot study offers valuable guidelines for the implementation of a future study on the 
effect of TENS combined with therapeutic exercises. Our strongest recommendation would 
be to select participants more sharply: a larger, gender-balanced sample will generate more 
reliable results that can be generalized to a larger population; and a more symptomatic sample 
will generate results that are less likely to be affected by a potential floor effect.  
Our results suggest that supplementing exercise sessions with TENS does not improve 
the overall outcome of elderly patients suffering from chronic pain, but does result in short-
term hypoalgesia throughout each training session. As such, it is plausible that this treatment 
approach might indirectly benefit a patient population, for example by improving tolerance to 
effort, or by decreasing maladaptive pain-related cognitions such as catastrophisation and 
kinesiophobia. Obviously, these are but speculations, and require much further investigation 
to be considered. Our results, as they stand, are promising enough to justify such investigation 
be undertaken.  
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Table 1 – Pain Questionnaires  
 Experimental Control 
T test  
(between-group) 
t ddl p-value 
Short-Form McGill Pain Questionnaire 
Mean T0 (SD) 13.2 (9.6) 18.4 (8.9) 1.20 16 0.25 
Mean T1 (SD) 10.3 (9.1) 19.8 (10.4) 2.06 16 0.06 
∆ [95% C.I.] 2.9 [-0.9, 6.7] -1.3 [-3.5, 0.9] -2.23 16 0.04 
Cohen's d 0.31 -0.14  
Paired t 
(within-
group) 
t 1.77 -1.39 
ddl 8 8 
p-value  0.12 0.20 
Brief Pain Inventory - severity 
Mean T0 (SD) 17.3 (8.9) 21.4 (8.0) 1.04 16 0.32 
Mean T1 (SD) 10.7 (10.1) 18.3 (12.2) 1.45 16 0.17 
∆ [95% C.I.] 6.7 [-2.9, 16.2] 3.1 [-1.5, 7.7] -0.78 16 0.45 
Cohen's d 0.70 0.30  
Paired t 
(within-
group) 
t 1.61 1.57 
ddl 8 8 
p-value  0.15 0.16 
Brief Pain Inventory - function 
Mean T0 (SD) 17.0 (13.9) 24.6 (16.8) 1.04 16 0.31 
Mean T1 (SD) 13.6 (13.9) 22.8 (19.5) 1.16 16 0.27 
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∆ [95% C.I.] 3.4 [-4.1, 11.0] 1.8 [-4.7, 8.3] -0.39 16 0.71 
Cohen's d 0.25 0.10  
Paired t 
(within-
group) 
t 1.05 0.63 
ddl 8 8 
p-value  0.32 0.55 
Beck Depression Index 
Mean T0 (SD) 9.0 (4.5) 10.2 (7.9) 0.40 16 0.69 
Mean T1 (SD) 8.9 (4.9) 11.0 (9.3) 0.61 16 0.55 
∆ [95% C.I.] 0.1 [-2.1, 2.3] -0.8 [-4.1, 2.6] -0.51 16 0.62 
Cohen's d 0.02 -0.09  
Paired t 
(within-
group) 
t 0.12 -0.54 
ddl 8 8 
p-value 0.91 0.61 
 
 
 
Table 1. Scores obtained in the experimental and control groups for the Short-Form McGill 
Pain Questionnaire; the Brief Pain Inventory; and the Beck Depression Index. 
 
 
 
  
29 
 
Table 2 – Average Hypoalgesia per Session 
Experimental group 
Session Session 1 Session 2 Session 3 Session 4 Session 5 Session 6     
Mean hypoalgesia (absolute) 2.0 0.3 2.8 1.9 1.4 2.2   
Mean hypoalgesia (relative) 33% 13% 45% 33% 22% 37%   
n= 4 3 5 7 5 5   
Control group 
Session Session 1 Session 2 Session 3 Session 4 Session 5 Session 6     
Mean hypoalgesia (absolute) 0.9 0.5 0.7 0.5 1.0 0.2   
Mean hypoalgesia (relative) 14% 7% 11% 10% 20% 3%   
n= 8 6 6 4 5 6   
Table 2. Absolute and relative hypoalgesia induced in each group over each session (n = 
number of participants for each session). 
Table 3 – Average Hypoalgesia per Participant 
Experimental group 
Subject  E1 E2 E3 E4 E5 E6 E7 E8 E9 
Mean hypoalgesia (absolute) 0.0 n/a 0.0 2.0 3.5 3.8 3.0 4.0 2.5 
Mean hypoalgesia (relative) 0% n/a -7% 36% 40% 96% 56% 100% 40% 
30 
 
n= 5 0 6 7 4 4 6 1 4 
Control group 
Subject  C1 C2 C3 C4 C5 C6 C7 C8 C9 
Mean hypoalgesia (absolute) 0.3 -0.1 0.3 4.0 2.5 0.5 0.3 0.3 1.4 
Mean hypoalgesia (relative) 8% -4% 4% 50% 100% 6% 4% 4% 29% 
n= 7 7 3 1 2 4 3 7 7 
Table 3. Average hypoalgesia (absolute and relative) induced in each participant (n= number 
of sessions attended for each participant). 
 
Table 4 – Average Hypoalgesia per Participant per Session 
  
Average hypoalgesia per 
participant per session 
Proportion of hypoalgesia-inducing sessions 
  Absolute Relative 
∆ pain score   
 ≥ 2 
∆ pain score    
 ≥ 30% 
∆ pain score  
≥ 50% 
Experimental 
group 
2.0 37% 59% 65% 35% 
Control group 0.6 14% 12% 15% 10% 
Table 4. Average hypoalgesia across all sessions and all participants (left); proportion of 
hypoalgesia-inducing sessions for each group (right).  
 
